老年多重用药研究现状与热点前沿的文献计量学分析 点击下载
论文标题: 老年多重用药研究现状与热点前沿的文献计量学分析
英文标题:
中文摘要: 目的:分析近10年老年多重用药的研究现状与热点前沿,为我国老年多重用药的研究提供参考。方法:检索2010年1月1日-2019年12月31日WebofScience数据库中核心数据库收录的老年多重用药相关的文献,采用CiteSpace5.6.R5软件对发文量、作者、国家/地区、机构、期刊共被引情况、文献共被引情况进行分析,对关键词进行共现分析、聚类分析及突现(Burst)分析,绘制可视化图谱并分析结果。结果:共纳入文献3521篇,老年多重用药研究的发文量整体呈上升趋势,高产作者主要以BellJS和HilmerSN为代表,均发表36篇,占总发文量的1.02%。美国(929篇,26.3%)和澳大利亚悉尼大学(101篇,2.87%)分别是发表文献最高产的国家和机构。JournaloftheAmericanGeriatricsSociety是收录文章最多的期刊(2202篇)。文献共被引频次最高是RadcliffS等在2015年发表的对Beers标准进行更新以用于减少潜在不适当用药的研究;文献共被引中心度最高是SpinewineA等在2007年发表的如何优化老年人处方的研究;关键词出现次数较多的包括老年人、多重用药、危险因素,中心度排名较高的包括􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂[42]胡燕君,李红磊,孙海,等.利西拉来联用口服降糖药治疗etal.Anetworkmeta-analysiscomparingexenatideonceT2DM有效性与安全性的Meta分析[J].转化医学杂志,weeklywithotherGLP-1receptoragonistsforthetreat-2017,6(5):272-275.mentoftype2diabetesmellitus[J].DiabetesTher,2016,7[43]范玲,谢星星,范小冬,等.利司鲁肽治疗T2DM的系统评(1):27-43.价[J].中国医院药学杂志,2017,37(3):254-257.[47]DUQ,WANGYJ,YANGS,etal.Liraglutideforthetreat-[44]LIW,GOUJ,TIANJ,etal.Glucagon-likepeptide-1re-mentoftype2diabetesmellitus:ameta-analysisofran-ceptoragonistsversusinsulinglarginefortype2diabetesdomizedplacebo-controlledtrials[J].AdvTher,2014,31mellitus:asystematicreviewandmeta-analysisofran-(11):1182-1195.domizedcontrolledtrials[J].CurrTherResClin,2010,71[48]AVGERINOSI,KARAGIANNIST,MALANDRISK,(4):211-238.etal.Glucagon-likepeptide-1receptoragonistsandmicro-[45]PINELLINR,HURRENKM.Efficacyandsafetyoflong-vascularoutcomesintype2diabetes:asystematicreviewactingglucagon-likepeptide-1receptoragonistscom-andmeta-analysis[J].DiabetesObesMetab,2019,21(1):paredwithexenatidetwicedailyandsitagliptinintype2188-193.diabetesmellitus:asystematicreviewandmeta-analy-[49]DAID,MAOY,JINH,etal.Efficacyandhypoglycemicsis[J].AnnPharmacother,2011,45(7/8):850-862.riskofsitagliptininobese/overweightpatientswithtype2[46]KAYANIYILS,LOZANO-ORTEGAG,BENNETTHA,diabetescomparedwithGLP-1receptoragonists:ame-ta-analysis[J].Medicine,2019.DOI:10.1097/MD.00000-Δ基金项目:新疆维吾尔族自治区自然科学基金资助项目00000017081.(No.2013211A059)*硕士研究生。研究方向:老年护理。电话:0514-82053853。[50]杨克虎,刘雅莉,袁金秋,等.发展和完善中的系统评价再E-mail:1450868213@qq.com评价[J].中国循证儿科杂志,2011,6(1):59-62.#通信作者:教授,硕士生导师,博士。研究方向:老年护理。电(收稿日期:2020-07-14修回日期:2020-09-07)话:0514-82053853。E-mail:bingbing19950806@163.com(编辑:刘明伟)·2664·ChinaPharmacy2020Vol.31No.21中国药房2020年第31卷第21期生活质量、多重用药、Beers标准,目前研究的热点包括危险因素、结局指标以及对多重用药的减少策略;形成Breastcancer、Pre-scription、Disorder、Schizophrenia、Medicationadherence、Trial等6个聚类;研究前沿是并发症、痛苦、老年衰弱、健康相关质量、认知障碍。结论:近10年来老年多重用药的研究日趋受到学者的重视,美国以及澳大利亚在该领域的贡献较大;研究主要集中在多重用药对健康结局的影响以及减少多重用药的策略上;未来可能会更多关注于多重用药对老年心理和认知、衰弱的相关研究。
英文摘要: OBJECTIVE:To analyze the research status and hotspot frontier of polypharmacy in the elderly in recent ten years , and to provide reference for polypharmacy study in the elderly in China. METHODS :The related literatures about polypharmacy in the elderly were retireved from Web of Science core database during Jan. 1st,2010-Dec. 31th,2019. CiteSpace 5.6.R5 software was used to analyze the quantity of pulished literatures ,authors,country/area,institution,co-citation of journals and literatures. The keywords were taken as nodes for co-occurrence analysis ,cluster analysis and Burst analysis ,the visual maps were drawn and the results were analyzed. RESULTS :A total of 3 521 literatures were included ,and the quantity of published literatures about polypharmacy in the elderly was on the rise ;high-yield authors mainly were Bell JS and Hilmer SN which were the representative with 36 papers published ,accounting for 1.02% of the total. America (929 literaturesm 26.3%)and University of Sydney (101 literatures,2.87%)were the most high-yield country and institution respectively ;Journal of the American Geriatrics Society was the journal with the most articles (2 202 pieces). The most frequently cited literature was those published by Radcliff S team in 2015 to update Beers standard to reduce potential inappropriate drug use ;the research on how to optimize the prescription for the elderly published by Spinewine A team in 2007 had the highest co-citation centrality. The hot keywords were elderly ,polypharmacy and risk factor ;keywords with high centrality included quality of life ,polypharmacy and Beers standard. Research hotspots included risk factor ,outcome index and reduction strategy for polypharmacy. Six clusters were formed ,including Breast cancer , Prescription,Disorder,Schizophrenia,Mediation attachment and Trial ;complications,pain,frailty,health-related quality , intellectual disability were at the forefront of research. CONCLUSIONS :In the past 10 years,the research on polypharmacy in the elderly has been paid more and more attention by scholars ;the United States and Australia have made great contributions in this field;the research mainly focused on the impact of polypharmacy on health outcomes and the strategies for reduce polypharmacy. In the future ,more attention will be paid to the related research on psychological ,cognitive and debilitating effects of polypharmacy in the elderly.
期刊: 2020年第31卷第21期
作者: 渠吉皊,沈易静,周婷,刘永兵
英文作者: QU Jiling,SHEN Yijing,ZHOU Ting,LIU Yongbing
关键字: 老年人;多重用药;文献计量学;Web of Science
KEYWORDS: Elderly;Polypharmacy;Bibliometrics;Web of Science
总下载数: 81次
本日下载数: 2次
本月下载数: 81次
文件大小: 619.60Kb

* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!